Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years

Diverse trends in clinical trial initiation across top US and EU locations

__timestampM D Anderson Cancer Center, Houston, Texas, 77030, United StatesMayo Clinic in Rochester, Rochester, Minnesota, 55905, United StatesNYU Langone Health, New York, New York, 10016, United StatesNational Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United StatesUniversity of Michigan, Ann Arbor, Michigan, 48109, United States
Friday, January 1, 202117155135
Saturday, January 1, 20227164537541
Sunday, January 1, 20238149396954
Monday, January 1, 20242836328429
Wednesday, January 1, 20253111
Loading chart...

Unleashing the power of data

In the last three years, clinical trials initiated in the US and EU have shown varying trends. The M D Anderson Cancer Center in Houston, Texas, led the way with an impressive 70% increase in trial count, followed closely by the National Institutes of Health Clinical Center in Bethesda, Maryland, with a 45% rise. However, some locations like NYU Langone Health in New York saw a modest 25% growth. Surprisingly, there was a significant drop in trials at the Massachusetts General Hospital in Boston, Massachusetts, with only a 1% increase. The Mayo Clinic in Rochester, Minnesota, also experienced fluctuations in trial initiation. These trends highlight the dynamic nature of clinical research across different regions.

Published by
National Center for Biotechnology Information

Source link
clinicaltrials.gov

Date published
20 Jun 2024